Among the companies expected to actively trade in Monday's
session are Nu Skin Enterprises Inc. (NUS) and Herbalife Ltd.
(HLF).
Nu Skin said Chinese regulators levied $540,000 in fines and
penalties against the direct marketer following a review of the
company's sales and promotional practices. The regulators said
certain products were permitted for sale in retail stores but
weren't registered for the direct-selling channel. Shares rose 25%
to $93.99 in premarket trading on investor relief that the penalty
wasn't higher.
The relatively light penalty also buoyed shares of Herbalife,
whose business has also faced scrutiny in China. Separately, the
supplement producer said it has agreed to nominate three more
designees of activist investor Carl C. Icahn to its board, days
after the company had delayed its annual meeting. Shares climbed 7%
to $53 premarket.
Watch List:
ITT Educational Services Inc. (ESI) said it failed to file its
annual report by its extended due date, as the for-profit educator
works to complete a review of its accounting practices related to a
certain private student-loan program.
J.C. Penney Co. (JCP) Chief Executive Myron E. Ullman will get a
sizable bump in pay this year. Mr. Ullman is due to receive a base
salary of $1.5 million in 2014, while last year he made more than
$810,000. He also made nearly $1.6 million in other compensation
last year--more than $913,000 of it coming from personal use of the
corporate aircraft.
Palo Alto Networks (PANW) on Monday said it had agreed to buy
Israeli cybersecurity company Cyvera for about $200 million.
Privately held Cyvera boasts an understanding of how hackers
exploit software vulnerabilities as well as a "unique method" to
prevent cyber attacks in real time.
Private-equity firm Blackstone Group L.P. (BX) plans to sell off
another 15 million shares in SeaWorld Entertainment Inc. (SEAS),
cutting down its holding to about 25%. At the stock's current
market value, Blackstone would raise about $500 million from the
sale, not including an underwriter option. The firm's stake is
currently around 43%.
St. Jude Medical Inc. (STJ) said the U.S. Food and Drug
Administration granted approvals for three of the medical-device
maker's pacemakers including its Allure Quadra. "In international
markets where the Allure Quadra CRT pacemaker is available, we
experience strong demand and significant share capture as the
technology has become the standard of care for many physicians,"
said Eric S. Fain, group president.
Write to Lauren Pollock at lauren.pollock@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires